Immune globulin (GC Biopharma)

N/A

Report date: 2023/12/19 20:05:05

Base Information

Drug NameImmune globulin (GC Biopharma)
Drug Alias NameHuman Immune Globulin(GC Biopharma)IGIV-SN(GC Biopharma)AlygloGC5101BGC-5107 +[8] 
ClassificationBiologics > Blood components
Mechanisms of ActionImmunostimulantsAmyloid beta-protein precursor inhibitors
TargetsAmyloid beta-protein precursor
Therapy Area/IndicationsImmunologic Deficiency SyndromesPrimary Immunodeficiency DiseasesAgammaglobulinemia +[6] 
Global Approved IndicationsPrimary Immunodeficiency Diseases
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryBosnia and HerzegovinaCanadaUnited States +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGC Biopharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesGC Biopharma Corp
Inactive CompaniesGreen Cross Holdings Co Ltd
Active IndicationsPrimary Immunodeficiency DiseasesAgammaglobulinemiaMucocutaneous Lymph Node Syndrome +[5] 
Inactive IndicationsImmunologic Deficiency Syndromes

Other Information

ATC CodeJ06BA02
Related LinksDrugBankKEGG